FIELD: organic chemistry. SUBSTANCE: product: new compounds of the general formula: (R1O)n-Y-R (I) where: Y - naphthyl, tetrahydronaphthyl, quinolyl, indolyl; R - group of the formulas: , or their pharmaceutically acceptable salts and pharmaceutical composition that inhibits activity of tyrosine kinase. Composition involves acceptable carrier or vehicle and an active component - compound of the formula (I) (R1O)n taken at effective dose. EFFECT: improved method of synthesis, enhanced effectiveness. 5 cl, 2 tbl
Authors
Dates
1997-09-27—Published
1991-02-26—Filed